Elon Musk’s Neuralink says it has FDA approval to study brain implants in humans
May 25 (Reuters) – Neuralink, Elon Musk’s brain implant company, said on Thursday that the U.S. Food and Drug Administration (FDA) had given the green light to its first human clinical trial, a critical step after earlier difficulties in obtaining approval. The FDA approval “represents an important first step that will one day allow our … Read more